Embolic Protection Devices Market 2021-2027
発行: Orion Market Research Pvt Ltd
Global Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)
The embolic protection devices market is anticipated to grow at a rapid CAGR of 8.0% during the forecast period. Embolic protection devices are used for various indications such as SVG, carotid artery disease and others, including AS, PAD, and acute myocardial infarction. Epidemiological studies stated, up to 12% of SVGs become occluded within the first six months after coronary artery bypass graft (CABG), with approximately 3.4% occluding as early as second to third weeks.
Multiple clinical studies published, the use of EPDs has reduced the 30-day major adverse cardiovascular events (MACE) rate by 40-50%. As embolization during endovascular interventional procedures has become increasingly prevalent, and most likely, all endovascular interventions generate embolic material. Careful use of EPDs to avoid atheroembolization during arterial interventions improves the clinical outcome in carotid, coronary and lower extremity artery interventions. Therefore, gaining significant popularity with the rising burden of various cardiac diseases globally.
The embolic protection devices market is segmented based on product, application, and end-user. Based on product, the market is segmented into filter devices and occlusion devices. Based on application, the market is categorized into cardiovascular & peripheral and neurovascular. Based on end-user, the market is fragmented into ambulatory surgery centers, freestanding CATH labs, hospitals, and specialty cardiac centers. In 2019, the cardiovascular & peripheral application segment accounted for the largest share of more than 60.0% of the global embolic protection devices market. PCI (Percutaneous Coronary Intervention) with stent placement is the most widely used revascularization procedure for SVG (Saphenous Vein Graft) lesions. Both cardiovascular & peripheral interventions with the percutaneous technique are associated with critical risk of distal embolization, which limits the clinical benefit to the patient. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiovascular & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. Therefore, market players are offering innovative EPDs suitable for cardiovascular & peripheral interventions.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe is one of the significant markets for embolic protection devices, accounting for a large share in 2019. The rising awareness of embolic protection devices for treating various embolic complications associated with treatment procedures of CAD, PAD and valvular heart diseases coupled with improved healthcare infrastructure, various favorable guidelines and availability of technologically advanced embolic protection devices are driving the growth of the embolic protection devices market in the region.
Lastly, vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market for several years. Such inorganic initiatives will complement vendors' organic growth strategies, thereby gaining traction among end-users in the market. The market is dominated by Boston Scientific, Abbott, and Medtronic. Boston Scientific is the market leader with its innovative product line of SENTINEL Cerebral Protection System, FilterWire EZ, Sentry, and FILTERWIRE EZ Embolic Protection System for SVGs for a wide range of indications, including SVG, carotid artery disease, and others.
The market study of the global embolic protection devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include
Financial reports of companies involved in the market.
Whitepapers, research-papers, and news blogs.
Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Global Embolic Protection Devices Market Research and Analysis by Product
Global Embolic Protection Devices Market Research and Analysis by Application
Global Embolic Protection Devices Market Research and Analysis by End-user
The Report Covers
Comprehensive research methodology of the global embolic protection devices market.
This report also includes a detailed and extensive market overview with the key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global embolic protection devices market.
Insights about market determinants which are stimulating the global embolic protection devices market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.